Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing
Ceribell (Nasdaq: CBLL) announced two key leadership appointments: Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing. Rodenbush brings 25+ years of HR experience and will lead the People & Culture team, having previously served as CPO at Meltwater. Price, with 25+ years in medical device industry experience, will focus on market development and penetration, coming from roles at VitalConnect, Medtronic, and Abbott. The appointments aim to support Ceribell's expansion of its AI-powered EEG neurodiagnostic system, addressing a significant market where up to one-third of ICU patients risk nonconvulsive seizures.
Ceribell (Nasdaq: CBLL) ha annunciato due importanti nomine nel suo leadership team: Kristie Rodenbush come Chief People Officer e Brian Price come Senior Vice President del Marketing. Rodenbush porta con sé oltre 25 anni di esperienza nel HR e guiderà il team People & Culture, avendo precedentemente ricoperto il ruolo di CPO presso Meltwater. Price, con oltre 25 anni di esperienza nell'industria dei dispositivi medici, si concentrerà sullo sviluppo e sulla penetrazione del mercato, provenendo da ruoli precedenti in VitalConnect, Medtronic e Abbott. Le nomine mirano a sostenere l'espansione del sistema neurodiagnostico EEG potenziato dall'IA di Ceribell, affrontando un mercato significativo in cui fino a un terzo dei pazienti in terapia intensiva rischia di avere crisi non convulsive.
Ceribell (Nasdaq: CBLL) anunció dos nombramientos clave en su equipo de liderazgo: Kristie Rodenbush como Directora de Personas y Brian Price como Vicepresidente Senior de Marketing. Rodenbush aporta más de 25 años de experiencia en recursos humanos y liderará el equipo de Personas y Cultura, habiendo ocupado anteriormente el puesto de CPO en Meltwater. Price, con más de 25 años de experiencia en la industria de dispositivos médicos, se enfocará en el desarrollo y la penetración del mercado, viniendo de roles en VitalConnect, Medtronic y Abbott. Los nombramientos buscan apoyar la expansión del sistema neurodiagnóstico EEG potenciado por IA de Ceribell, abordando un mercado significativo donde hasta un tercio de los pacientes en UCI corre el riesgo de tener convulsiones no convulsivas.
Ceribell (Nasdaq: CBLL)가 두 가지 주요 리더십 임명을 발표했습니다: Kristie Rodenbush를 최고 인사 책임자 및 Brian Price를 마케팅 수석 부사장으로 임명했습니다. 로덴부시는 25년 이상의 인사 경험을 가지고 있으며, 이전에 멜트워터에서 CPO로 일한 경력이 있습니다. 프라이스는 의료기기 산업에서 25년 이상의 경력을 바탕으로 시장 개발과 침투에 집중할 예정이며, 바이탈커넥트, 메드트로닉, 아보트 등에서 활동했습니다. 이 임명들은 Ceribell의 AI 기반 EEG 신경 진단 시스템 확장을 지원하기 위한 것으로, 중환자실 환자의 최대 3분의 1이 비발작적인 경련을 겪을 위험이 있는 중요한 시장을 다루고 있습니다.
Ceribell (Nasdaq: CBLL) a annoncé deux nominations clés au sein de son équipe de direction : Kristie Rodenbush en tant que Directrice des Ressources Humaines et Brian Price en tant que Vice-Président Senior du Marketing. Rodenbush apporte plus de 25 ans d'expérience en ressources humaines et dirigera l'équipe People & Culture, ayant précédemment occupé le poste de CPO chez Meltwater. Price, fort de plus de 25 ans d'expérience dans l'industrie des dispositifs médicaux, se concentrera sur le développement et la pénétration du marché, venant de rôles chez VitalConnect, Medtronic et Abbott. Ces nominations visent à soutenir l'expansion du système neurodiagnostique EEG alimenté par l'IA de Ceribell, répondant à un marché significatif où jusqu'à un tiers des patients en soins intensifs risquent de subir des crises non convulsives.
Ceribell (Nasdaq: CBLL) hat zwei wichtige Führungspositionen bekannt gegeben: Kristie Rodenbush als Chief People Officer und Brian Price als Senior Vice President für Marketing. Rodenbush bringt über 25 Jahre Erfahrung im Personalwesen mit und wird das Team People & Culture leiten, nachdem sie zuvor als CPO bei Meltwater tätig war. Price, der über 25 Jahre Erfahrung in der Medizintechnikbranche verfügt, wird sich auf Marktentwicklung und -penetration konzentrieren und kommt aus Positionen bei VitalConnect, Medtronic und Abbott. Die Ernennungen zielen darauf ab, Ceribells Expansion des KI-gestützten EEG-Neurodiagnosesystems zu unterstützen, das einen bedeutenden Markt anspricht, in dem bis zu ein Drittel der Intensivpatienten das Risiko von nicht-anfallsartigen Anfällen hat.
- Strategic expansion of leadership team with experienced executives
- Large addressable market with one-third of ICU patients at risk for nonconvulsive seizures
- FDA 510(k) clearance already obtained for the Ceribell System
- None.
—Ms. Rodenbush to lead hiring and talent development initiatives—
—Mr. Price to focus on market development and penetration—
SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions (“Ceribell”), today announced the appointments of Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing to its leadership team.
“Ms. Rodenbush and Mr. Price bring an impressive wealth of experience to Ceribell, and I am confident that their leadership across our People & Culture and Marketing functions will help us strategically expand our growing team and commercial footprint as we focus on bringing our AI-powered point-of-care EEG neurodiagnostic system to even more hospitals, providing benefit to more patients and providers,” said Jane Chao, Ph.D., co-founder and CEO of Ceribell. “The magnitude of the unmet need we are addressing is massive: up to one-third of ICU patients are at risk for nonconvulsive seizures. We are proud of our market penetration to date, but there is a significant opportunity for continued growth. Ms. Rodenbush and Mr. Price are important additions to our team, and will play key roles in driving our vital growth initiatives.”
Kristie Rodenbush, Chief People Officer
Ms. Rodenbush will oversee Ceribell’s People & Culture team. She has more than 25 years of human resources and talent management experience which spans various industries and includes roles at companies ranging from startups to publicly traded, international organizations. Most recently, she served as Chief People Officer of Meltwater, where she led human resources functions for more than 2,400 employees located in 30 countries. Ms. Rodenbush holds a Bachelor of Arts in Psychology from the University of California, San Diego.
Brian Price, Senior Vice President of Marketing
Mr. Price is an industry veteran who brings to Ceribell more than 25 years of experience in the medical device industry, including marketing leadership roles at Medtronic and Abbott. In his new role at Ceribell, he will leverage his expertise in market development, product portfolio planning, business development, health economics, reimbursement and sales. He most recently served as Chief Marketing Officer of VitalConnect, and previously held sales and marketing leadership roles with LivaNova, St. Jude Medical, WebMD and Guidant Corporation, where he drove multiple incremental product launches and disruptive therapy platforms across many specialties including neurology, cardiology, urology and gynecology. Mr. Price holds a Master of Business Administration degree from the University of Minnesota Carlson School of Management and a Bachelor of Science in Organizational Leadership and Industrial Technology from Purdue University.
About CeriBell Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.
MEDIA CONTACT
Corrie Rose
press@ceribell.com
INVESTOR CONTACTS
Brian Johnston
Laine Morgan
investors@ceribell.com
FAQ
What are the recent executive appointments at Ceribell (CBLL)?
What is Kristie Rodenbush's background before joining Ceribell (CBLL)?
What is Brian Price's experience prior to Ceribell (CBLL)?
What is the market opportunity for Ceribell's (CBLL) EEG system?
